Skip to Content

144 (Dutrebis lamivudine 150 mg / raltegravir 300 mg)

Generic Name: lamivudine/raltegravir

Pill with imprint 144 is Green, Elliptical / Oval and has been identified as Dutrebis lamivudine 150 mg / raltegravir 300 mg. It is supplied by Merck & Co., Inc..

Dutrebis is used in the treatment of hiv infection and belongs to the drug class antiviral combinations. Risk cannot be ruled out during pregnancy. Dutrebis lamivudine 150 mg / raltegravir 300 mg is not a controlled substance under the Controlled Substance Act (CSA).

Images for 144

Dutrebis

Generic Name:
lamivudine/raltegravir
Imprint:
144
Strength:
lamivudine 150 mg / raltegravir 300 mg
Color:
Green
Shape:
Elliptical / Oval
Availability:
Prescription only
Drug Class:
Antiviral combinations
Pregnancy Category:
C - Risk cannot be ruled out
CSA Schedule:
Not a controlled drug
Labeler / Supplier:
Merck & Co., Inc.
National Drug Code (NDC):
00006-3054

Get help with Imprint Code FAQs.

More about Dutrebis (lamivudine / raltegravir)

Related treatment guides

Disclaimer: Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Copyright 2017 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.

Hide